SlideShare a Scribd company logo
90-90-90
An Ambitious treatment target to
help end the AIDS epidemic
Nancy Somi
What's 90-90-90?
A new HIV treatment narrative that lays the ground works to end the AIDS epidemic
• By 2020, 90% of all people living with HIV will know their HIV status.
• By 2020, 90% of all people with diagnosed HIV infection will receive sustained
antiretroviral therapy
• By 2020, 90% of all people receiving antiretroviral therapy will have viral suppression.
The target was initiated by UNAIDS under WHO.
Why the 90-90-90 Target
• Target will drive progress. Until December 2013 more than 60% of people
living with HIV lacked HIV treatment underscoring the need for intensified
efforts to bring HIV treatment to all those who need it
• Target guides action taken beyond 2015-Ending AIDS will require new
milestones to guide and accelerate progress in the post 2015 era
• Target promotes accountability-A clearly articulated goal enables diverse
stakeholders to identify respective roles and responsibilities.
• A bold Target undescores that ending AIDS epidemic is achievable-
Boldly grasping this challenge ensures that ending AIDS epidemic in the
world is possible by 2030.
How will 90-90-90 succeed
• Focus on the new quality and outcomes of antiretroviral therapy as
treatment services are scaled up.
• The new target captures both the therapeutic and preventive benefits of
HIV treatment.
• It prioritizes equity- Unless all communities affected by HIV have full and
equitable access to life saving treatment and other prevention services the
world will not end the AIDS epidemic.
First 90:90% diagnosed
• African countries are either approaching or within the striking distance of
having at least 90% of people living with HIV/AIDS tested at least.
• Until December 2013 only 45% of people living with HIV knew their status
in sub-Saharan Africa.
• The gap underscores a need for more frequent testing.
• Testing in multi disease health campaigns in Kenya and Uganda increased the
testing coverage to 86% and 72%.
Second 90:90% on HIV treatment.
• High treatment coverage is also achieved in some settings e.g. in Botswana
and Colombia more than 70% of people diagnosed with HIV are now
receiving antiretroviral therapy.
• Recomending antiretroviral therapy to all people with HIV infection without
requiring prior CD4 count will enhance treatment and reduce loss to follow
up.
• Countries will need to implement issues that slow up implemtation like;
pharmacy stock outs, procurement of medicnes and second and third line
regimens.
Last 90:90%Viral Suppressed
• High levels of viral suppression have been achieved in some countries e.g 17
countries in Latin America and Carribean countries have 66% of those
diagnosed are viral suppressed.
• Viral suppression doesn’t count for AIDS related mortality or loss to follow
up highlighting efforts to retain those who are loss to follow among the ones
enrolled in care.
• Viral load testing will lower treatment costs and help clinicians identify early
treatment failure.
Last 90 contd…..
• Ensuring universal access to viral load testing in all settings is vital.
• UNAIDS,WHO, ASLM and US CDC jointly convened the role of
laboratory medicine in meeting the 90-90-90 targets in June 2014
• The meeting was aimed at building robust, sustainability laboratory capacity
that will be needed to meet the global treatment goals
Challenges along the road!
• Societal Challenges- Stigma, discrimination
• Delivery Challenges-Centralization of treatment centers reduces success of
treatment. Strategies should be tailored by stakeholders to make sure even
those in remote areas can access HIV treatment.
• Costs of achieving the 90-90-90 target-Increased funding will be needed to
end the AIDS epidemic.Costs are incured in drugs,delivery service,laboratory
capacity and community mobilization to ensure testing and retention in care.
90 90-90

More Related Content

What's hot

Subfertility (Infertility)
Subfertility (Infertility)Subfertility (Infertility)
Subfertility (Infertility)
Abdullah Mohammad
 
History taking format for gyne
History taking format for gyneHistory taking format for gyne
History taking format for gyne
Bibëk Bhandari
 
National medical commission ppt with MCQs by dr MB singh
National medical commission ppt with MCQs by dr MB singhNational medical commission ppt with MCQs by dr MB singh
National medical commission ppt with MCQs by dr MB singh
balaji singh
 
Vesicovaginal fistula evaluation
Vesicovaginal fistula evaluation Vesicovaginal fistula evaluation
Vesicovaginal fistula evaluation
Mohammed Abd El Wadood
 
Lecture 9 professionalism in medical practice (06.03.2017)
Lecture 9  professionalism in medical practice (06.03.2017)Lecture 9  professionalism in medical practice (06.03.2017)
Lecture 9 professionalism in medical practice (06.03.2017)
Dr Ghaiath Hussein
 
commercial-sex-workers-an-overview-of-the-terminology-and-intervention-design
commercial-sex-workers-an-overview-of-the-terminology-and-intervention-designcommercial-sex-workers-an-overview-of-the-terminology-and-intervention-design
commercial-sex-workers-an-overview-of-the-terminology-and-intervention-design
Suresh Murugan
 
Emergency Contraception
Emergency ContraceptionEmergency Contraception
Emergency Contraception
CONSULTANT IN OBGYN, ODISHA ,INDIA
 
Jssk power point presentation
Jssk power point presentationJssk power point presentation
Jssk power point presentation
Gagan Kaur
 
Dr rabi postpartum contraception
Dr rabi postpartum contraceptionDr rabi postpartum contraception
Dr rabi postpartum contraception
Rabi Satpathy
 
Family planning
Family planning Family planning
Family planning
tariggally
 
Cesarean section and associated surgeries from the same incision
Cesarean  section and associated surgeries from the same incisionCesarean  section and associated surgeries from the same incision
Cesarean section and associated surgeries from the same incision
muhammad al hennawy
 
Sexaually Transmitted Infections and Reproductive Tract Infections
Sexaually Transmitted Infections and Reproductive Tract Infections Sexaually Transmitted Infections and Reproductive Tract Infections
Sexaually Transmitted Infections and Reproductive Tract Infections
Abhishek Agarwal
 
Cervical Biopsy - Obstetrics & Gynaecology
Cervical Biopsy - Obstetrics & GynaecologyCervical Biopsy - Obstetrics & Gynaecology
Cervical Biopsy - Obstetrics & Gynaecology
Apoorva Kottary
 
Management of Preterm labor
 Management of Preterm labor Management of Preterm labor
Management of Preterm labor
sunil kumar daha
 
Perinatal HIV- Prevention of Parent to child transmission (PPTCT)
Perinatal HIV- Prevention of Parent to child transmission (PPTCT)Perinatal HIV- Prevention of Parent to child transmission (PPTCT)
Perinatal HIV- Prevention of Parent to child transmission (PPTCT)
University college of Medical Sciences, Delhi
 
Prevention of occupational diseases
Prevention of occupational diseasesPrevention of occupational diseases
Prevention of occupational diseases
Arun Raj
 
Abuse of elders
Abuse of eldersAbuse of elders
Abuse of elders
DEVA PON PUSHPAM I
 
Adolescent Reproductive Sexual Health(ARSH)
Adolescent Reproductive Sexual Health(ARSH)Adolescent Reproductive Sexual Health(ARSH)
Adolescent Reproductive Sexual Health(ARSH)
Vaishali Talani
 
HEALTH CARE PROBLEMS IN INDIA
HEALTH CARE PROBLEMS IN INDIAHEALTH CARE PROBLEMS IN INDIA
HEALTH CARE PROBLEMS IN INDIA
MAHESWARI JAIKUMAR
 
Abortion and post abortion care
Abortion and post abortion careAbortion and post abortion care
Abortion and post abortion care
Mesfin Mulugeta
 

What's hot (20)

Subfertility (Infertility)
Subfertility (Infertility)Subfertility (Infertility)
Subfertility (Infertility)
 
History taking format for gyne
History taking format for gyneHistory taking format for gyne
History taking format for gyne
 
National medical commission ppt with MCQs by dr MB singh
National medical commission ppt with MCQs by dr MB singhNational medical commission ppt with MCQs by dr MB singh
National medical commission ppt with MCQs by dr MB singh
 
Vesicovaginal fistula evaluation
Vesicovaginal fistula evaluation Vesicovaginal fistula evaluation
Vesicovaginal fistula evaluation
 
Lecture 9 professionalism in medical practice (06.03.2017)
Lecture 9  professionalism in medical practice (06.03.2017)Lecture 9  professionalism in medical practice (06.03.2017)
Lecture 9 professionalism in medical practice (06.03.2017)
 
commercial-sex-workers-an-overview-of-the-terminology-and-intervention-design
commercial-sex-workers-an-overview-of-the-terminology-and-intervention-designcommercial-sex-workers-an-overview-of-the-terminology-and-intervention-design
commercial-sex-workers-an-overview-of-the-terminology-and-intervention-design
 
Emergency Contraception
Emergency ContraceptionEmergency Contraception
Emergency Contraception
 
Jssk power point presentation
Jssk power point presentationJssk power point presentation
Jssk power point presentation
 
Dr rabi postpartum contraception
Dr rabi postpartum contraceptionDr rabi postpartum contraception
Dr rabi postpartum contraception
 
Family planning
Family planning Family planning
Family planning
 
Cesarean section and associated surgeries from the same incision
Cesarean  section and associated surgeries from the same incisionCesarean  section and associated surgeries from the same incision
Cesarean section and associated surgeries from the same incision
 
Sexaually Transmitted Infections and Reproductive Tract Infections
Sexaually Transmitted Infections and Reproductive Tract Infections Sexaually Transmitted Infections and Reproductive Tract Infections
Sexaually Transmitted Infections and Reproductive Tract Infections
 
Cervical Biopsy - Obstetrics & Gynaecology
Cervical Biopsy - Obstetrics & GynaecologyCervical Biopsy - Obstetrics & Gynaecology
Cervical Biopsy - Obstetrics & Gynaecology
 
Management of Preterm labor
 Management of Preterm labor Management of Preterm labor
Management of Preterm labor
 
Perinatal HIV- Prevention of Parent to child transmission (PPTCT)
Perinatal HIV- Prevention of Parent to child transmission (PPTCT)Perinatal HIV- Prevention of Parent to child transmission (PPTCT)
Perinatal HIV- Prevention of Parent to child transmission (PPTCT)
 
Prevention of occupational diseases
Prevention of occupational diseasesPrevention of occupational diseases
Prevention of occupational diseases
 
Abuse of elders
Abuse of eldersAbuse of elders
Abuse of elders
 
Adolescent Reproductive Sexual Health(ARSH)
Adolescent Reproductive Sexual Health(ARSH)Adolescent Reproductive Sexual Health(ARSH)
Adolescent Reproductive Sexual Health(ARSH)
 
HEALTH CARE PROBLEMS IN INDIA
HEALTH CARE PROBLEMS IN INDIAHEALTH CARE PROBLEMS IN INDIA
HEALTH CARE PROBLEMS IN INDIA
 
Abortion and post abortion care
Abortion and post abortion careAbortion and post abortion care
Abortion and post abortion care
 

Viewers also liked

Menú especial
Menú especialMenú especial
Menú especial
durancasals
 
Benjamin Wardell | Recruiters Campaign CV | Contracting
Benjamin Wardell | Recruiters Campaign CV | ContractingBenjamin Wardell | Recruiters Campaign CV | Contracting
Benjamin Wardell | Recruiters Campaign CV | Contracting
Benjamin Wardell | Digital | Marketing | Social | Brand
 
"Ελίτσα Μαυρομάτα" από την Έφη
"Ελίτσα Μαυρομάτα" από την Έφη"Ελίτσα Μαυρομάτα" από την Έφη
"Ελίτσα Μαυρομάτα" από την Έφη
magdalinikalatheri
 
Fire 3 prevention
Fire 3 preventionFire 3 prevention
Fire 3 prevention
soumenmakar
 
Error correction 3 mon+wed c1.2
Error correction 3 mon+wed c1.2Error correction 3 mon+wed c1.2
Error correction 3 mon+wed c1.2
jeanphilippeguy
 
Trabajo transmision
Trabajo transmisionTrabajo transmision
Trabajo transmision
sidiellopez
 
How are messaging apps reinventing social media?
How are messaging apps reinventing social media?How are messaging apps reinventing social media?
How are messaging apps reinventing social media?
Drew Benvie
 
Proyectos informaticos
Proyectos informaticosProyectos informaticos
Proyectos informaticos
adriana023
 
Presentación de roland
Presentación de rolandPresentación de roland
Presentación de roland
anyie gil
 
мо для пдф помірники
 мо для пдф помірники мо для пдф помірники
мо для пдф помірники
Надежда Сорока
 
Columbus Bar Association - Common Ethics Mistake Law Firms Make When Marketin...
Columbus Bar Association - Common Ethics Mistake Law Firms Make When Marketin...Columbus Bar Association - Common Ethics Mistake Law Firms Make When Marketin...
Columbus Bar Association - Common Ethics Mistake Law Firms Make When Marketin...
Get Noticed Get Found
 
Circuitos rlc (1)
Circuitos rlc (1)Circuitos rlc (1)
Circuitos rlc (1)
JORGE BENITEZ
 

Viewers also liked (12)

Menú especial
Menú especialMenú especial
Menú especial
 
Benjamin Wardell | Recruiters Campaign CV | Contracting
Benjamin Wardell | Recruiters Campaign CV | ContractingBenjamin Wardell | Recruiters Campaign CV | Contracting
Benjamin Wardell | Recruiters Campaign CV | Contracting
 
"Ελίτσα Μαυρομάτα" από την Έφη
"Ελίτσα Μαυρομάτα" από την Έφη"Ελίτσα Μαυρομάτα" από την Έφη
"Ελίτσα Μαυρομάτα" από την Έφη
 
Fire 3 prevention
Fire 3 preventionFire 3 prevention
Fire 3 prevention
 
Error correction 3 mon+wed c1.2
Error correction 3 mon+wed c1.2Error correction 3 mon+wed c1.2
Error correction 3 mon+wed c1.2
 
Trabajo transmision
Trabajo transmisionTrabajo transmision
Trabajo transmision
 
How are messaging apps reinventing social media?
How are messaging apps reinventing social media?How are messaging apps reinventing social media?
How are messaging apps reinventing social media?
 
Proyectos informaticos
Proyectos informaticosProyectos informaticos
Proyectos informaticos
 
Presentación de roland
Presentación de rolandPresentación de roland
Presentación de roland
 
мо для пдф помірники
 мо для пдф помірники мо для пдф помірники
мо для пдф помірники
 
Columbus Bar Association - Common Ethics Mistake Law Firms Make When Marketin...
Columbus Bar Association - Common Ethics Mistake Law Firms Make When Marketin...Columbus Bar Association - Common Ethics Mistake Law Firms Make When Marketin...
Columbus Bar Association - Common Ethics Mistake Law Firms Make When Marketin...
 
Circuitos rlc (1)
Circuitos rlc (1)Circuitos rlc (1)
Circuitos rlc (1)
 

Similar to 90 90-90

What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
European Centre for Disease Prevention and Control
 
Partnerships to end_AIDS by 2030
Partnerships to end_AIDS by 2030Partnerships to end_AIDS by 2030
Partnerships to end_AIDS by 2030
AIDS Watch Africa
 
The HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura WatersThe HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura Waters
ReShape
 
National strategic plan
National strategic planNational strategic plan
National strategic plan
Dr. Ghulam Mustafa Kataria
 
What is epidemic control after 2020 mwango 04082021
What is epidemic control after 2020 mwango 04082021What is epidemic control after 2020 mwango 04082021
What is epidemic control after 2020 mwango 04082021
Albert Mwango
 
HIV prevention-2020-road-map
HIV prevention-2020-road-mapHIV prevention-2020-road-map
HIV prevention-2020-road-map
Abdiwali Abdullahi Abdiwali
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
HopkinsCFAR
 
STD program.pptx
STD program.pptxSTD program.pptx
STD program.pptx
naveenithkrishnan
 
Global and Indian plan to End TB
Global and Indian plan to End TBGlobal and Indian plan to End TB
Global and Indian plan to End TB
Rama shankar
 
Post 2015 agenda & aids coordination
Post 2015 agenda & aids coordinationPost 2015 agenda & aids coordination
Post 2015 agenda & aids coordination
AIDS Watch Africa
 
2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf
HajrahHajrah5
 
Ncd ppt
Ncd pptNcd ppt
Ncd ppt
Vipin K Ravi
 
Viral hepatitis Elimination challenges and progress Final.pptx
Viral hepatitis Elimination challenges and progress Final.pptxViral hepatitis Elimination challenges and progress Final.pptx
Viral hepatitis Elimination challenges and progress Final.pptx
DrHarsh Saxena
 
National aids control program 4
National aids control program 4National aids control program 4
National aids control program 4
drrahul4publichealth
 
National AIDS Control Program - IV
National AIDS Control Program - IVNational AIDS Control Program - IV
National AIDS Control Program - IV
Bharat Paul
 
Global health sector strategy 2016-2021
Global health sector strategy 2016-2021Global health sector strategy 2016-2021
Global health sector strategy 2016-2021
Mayank Badola
 
achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020
achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020
achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020
Affonso Bennett-Williams
 
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptxNATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
KritikaDhawan9
 
END TB 2015 strategy
END TB 2015 strategyEND TB 2015 strategy
END TB 2015 strategy
Dr.Waseemsha ShanawazBasha
 
national aids control program phase IV
national aids control program phase IVnational aids control program phase IV
national aids control program phase IV
Arkadeb Kar
 

Similar to 90 90-90 (20)

What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
 
Partnerships to end_AIDS by 2030
Partnerships to end_AIDS by 2030Partnerships to end_AIDS by 2030
Partnerships to end_AIDS by 2030
 
The HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura WatersThe HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura Waters
 
National strategic plan
National strategic planNational strategic plan
National strategic plan
 
What is epidemic control after 2020 mwango 04082021
What is epidemic control after 2020 mwango 04082021What is epidemic control after 2020 mwango 04082021
What is epidemic control after 2020 mwango 04082021
 
HIV prevention-2020-road-map
HIV prevention-2020-road-mapHIV prevention-2020-road-map
HIV prevention-2020-road-map
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
 
STD program.pptx
STD program.pptxSTD program.pptx
STD program.pptx
 
Global and Indian plan to End TB
Global and Indian plan to End TBGlobal and Indian plan to End TB
Global and Indian plan to End TB
 
Post 2015 agenda & aids coordination
Post 2015 agenda & aids coordinationPost 2015 agenda & aids coordination
Post 2015 agenda & aids coordination
 
2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf
 
Ncd ppt
Ncd pptNcd ppt
Ncd ppt
 
Viral hepatitis Elimination challenges and progress Final.pptx
Viral hepatitis Elimination challenges and progress Final.pptxViral hepatitis Elimination challenges and progress Final.pptx
Viral hepatitis Elimination challenges and progress Final.pptx
 
National aids control program 4
National aids control program 4National aids control program 4
National aids control program 4
 
National AIDS Control Program - IV
National AIDS Control Program - IVNational AIDS Control Program - IV
National AIDS Control Program - IV
 
Global health sector strategy 2016-2021
Global health sector strategy 2016-2021Global health sector strategy 2016-2021
Global health sector strategy 2016-2021
 
achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020
achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020
achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020
 
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptxNATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
 
END TB 2015 strategy
END TB 2015 strategyEND TB 2015 strategy
END TB 2015 strategy
 
national aids control program phase IV
national aids control program phase IVnational aids control program phase IV
national aids control program phase IV
 

Recently uploaded

Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 

Recently uploaded (20)

Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 

90 90-90

  • 1. 90-90-90 An Ambitious treatment target to help end the AIDS epidemic Nancy Somi
  • 2. What's 90-90-90? A new HIV treatment narrative that lays the ground works to end the AIDS epidemic • By 2020, 90% of all people living with HIV will know their HIV status. • By 2020, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy • By 2020, 90% of all people receiving antiretroviral therapy will have viral suppression. The target was initiated by UNAIDS under WHO.
  • 3.
  • 4. Why the 90-90-90 Target • Target will drive progress. Until December 2013 more than 60% of people living with HIV lacked HIV treatment underscoring the need for intensified efforts to bring HIV treatment to all those who need it • Target guides action taken beyond 2015-Ending AIDS will require new milestones to guide and accelerate progress in the post 2015 era • Target promotes accountability-A clearly articulated goal enables diverse stakeholders to identify respective roles and responsibilities. • A bold Target undescores that ending AIDS epidemic is achievable- Boldly grasping this challenge ensures that ending AIDS epidemic in the world is possible by 2030.
  • 5. How will 90-90-90 succeed • Focus on the new quality and outcomes of antiretroviral therapy as treatment services are scaled up. • The new target captures both the therapeutic and preventive benefits of HIV treatment. • It prioritizes equity- Unless all communities affected by HIV have full and equitable access to life saving treatment and other prevention services the world will not end the AIDS epidemic.
  • 6. First 90:90% diagnosed • African countries are either approaching or within the striking distance of having at least 90% of people living with HIV/AIDS tested at least. • Until December 2013 only 45% of people living with HIV knew their status in sub-Saharan Africa. • The gap underscores a need for more frequent testing. • Testing in multi disease health campaigns in Kenya and Uganda increased the testing coverage to 86% and 72%.
  • 7. Second 90:90% on HIV treatment. • High treatment coverage is also achieved in some settings e.g. in Botswana and Colombia more than 70% of people diagnosed with HIV are now receiving antiretroviral therapy. • Recomending antiretroviral therapy to all people with HIV infection without requiring prior CD4 count will enhance treatment and reduce loss to follow up. • Countries will need to implement issues that slow up implemtation like; pharmacy stock outs, procurement of medicnes and second and third line regimens.
  • 8. Last 90:90%Viral Suppressed • High levels of viral suppression have been achieved in some countries e.g 17 countries in Latin America and Carribean countries have 66% of those diagnosed are viral suppressed. • Viral suppression doesn’t count for AIDS related mortality or loss to follow up highlighting efforts to retain those who are loss to follow among the ones enrolled in care. • Viral load testing will lower treatment costs and help clinicians identify early treatment failure.
  • 9. Last 90 contd….. • Ensuring universal access to viral load testing in all settings is vital. • UNAIDS,WHO, ASLM and US CDC jointly convened the role of laboratory medicine in meeting the 90-90-90 targets in June 2014 • The meeting was aimed at building robust, sustainability laboratory capacity that will be needed to meet the global treatment goals
  • 10.
  • 11. Challenges along the road! • Societal Challenges- Stigma, discrimination • Delivery Challenges-Centralization of treatment centers reduces success of treatment. Strategies should be tailored by stakeholders to make sure even those in remote areas can access HIV treatment. • Costs of achieving the 90-90-90 target-Increased funding will be needed to end the AIDS epidemic.Costs are incured in drugs,delivery service,laboratory capacity and community mobilization to ensure testing and retention in care.